A Study to Assess the Safety and Effect of TC-5214 in Patients With Major Depressive Disorder.

PHASE2TerminatedINTERVENTIONAL
Enrollment

145

Participants

Timeline

Start Date

February 28, 2011

Primary Completion Date

August 31, 2012

Study Completion Date

August 31, 2012

Conditions
Major Depressive Disorder
Interventions
DRUG

TC-5214

Tablet, oral, twice daily for 8 weeks

DRUG

Duloxetine

Capsule, oral, once daily

DRUG

Placebo

Tablet, oral, twice daily for 8 weeks

Trial Locations (63)

Unknown

Research Site, Beverly Hills

Research Site, Chino

Research Site, Garden Grove

Research Site, San Diego

Research Site, Torrance

Research Site, Bradenton

Research Site, Coral Springs

Research Site, Jacksonville

Research Site, North Miami

Research Site, St. Petersburg

Research Site, West Palm Beach

Research Site, Atlanta

Research Site, Joliet

Research Site, Prairie Village

Research Site, Flowood

Research Site, New York

Research Site, Rochester

Research Site, Dayton

Research Site, Mason

Research Site, Portland

Research Site, Allentown

Research Site, Dallas

Research Site, Houston

Research Site, Seattle

Research Site, Madison

Research Site, Tallinn

Research Site, Tartu

Research Site, Helsinki

Research Site, Jyväskylä

Research Site, Kuopio

Research Site, Tampere

Research Site, Visakhapatnam

Research Site, Ahmedabad

Research Site, Bangalore

Research Site, Bangalore

Research Site, Mangalore

Research Site, Nashik

Research Site, Jaipur

Research Site, Chennai

Research Site, Varanasi

Research Site, Kanpur

Research Site, Pune

Research Site, Nagoya

Research Site, Ichikawa

Research Site, Noda

Research Site, Fukuoka

Research Site, Omuta

Research Site, Sapporo

Research Site, Sapproro

Research Site, Akashi

Research Site, Kobe

Research Site, Kawasaki-shi

Research Site, Sagamihara-shi

Research Site, Yokohama

Research Site, Kumamoto

Research Site, Yatsushiro

Research Site, Ukyo-ku ,Kyoto

Research Site, Kurashiki-shi

Research Site, Kodaira-shi

Research Site, Meguro-ku

Research Site, Minato-ku

Research Site, Setagaya-ku

Research Site, Shinagawa-ku

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY